<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Immunic Hopes for Trial Results in 2020
Image Overlay - Immunic Hopes for Trial Results in 2020

Immunic Hopes for Trial Results in 2020

June 25, 2020

Immunic Hopes for Trial Results in 2020

Immunic has commenced phase II CALVID-1 clinical trials of their IMU-838 therapy to treat patients with coronavirus. The U.S.-based biotech firm expects trial results later in the year. Yourway has the global capacity to transport sensitive trial materials and deliver trial material directly to patients.

 Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Pharma Supply Chain & Logistics Innovation Programme EU

May 20-21, 2026
Basel, Switzerland

Clinical Trial Supply West Coast

September 22-23, 2026
Burlingame, CA

Media

Articles

Global Reach in Clinical Trials: Beyond Presence to True Execution

Open chat
Come chat with us!
Hello! How can I help you?